Literature DB >> 6227104

Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes--a multicentre trial.

Z S Latallo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6227104

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  6 in total

1.  Effects of enzymatic blood defibrination in subcortical arteriosclerotic encephalopathy.

Authors:  E B Ringelstein; A Mauckner; R Schneider; W Sturm; W Doering; S Wolf; N Maurin; K Willmes; M Schlenker; H Brückmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-08       Impact factor: 10.154

Review 2.  Disseminated intravascular coagulation: diagnosis and treatment.

Authors:  T Baglin
Journal:  BMJ       Date:  1996-03-16

3.  Uses of heparin. Ancrod for heparin induced thrombocytopenia.

Authors:  R L Soutar; J S Ginsberg
Journal:  BMJ       Date:  1993-05-22

Review 4.  Snake venoms.

Authors:  F S Markland
Journal:  Drugs       Date:  1997       Impact factor: 9.546

5.  Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin.

Authors:  Trang T Vu; Alan R Stafford; Beverly A Leslie; Paul Y Kim; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

6.  Molecular cloning and sequence analysis of the cDNA for ancrod, a thrombin-like enzyme from the venom of Calloselasma rhodostoma.

Authors:  L C Au; S B Lin; J S Chou; G W Teh; K J Chang; C M Shih
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.